Search
for
Sort by
Research 121–150 of 230
- 69 Risk-benefit appraisal of systemic JAK inhibitors for alopecia areata: a comprehensive meta-analysis assessing safety and adverse effects
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Effective treatment of alopecia universalis with oral tofacitinib: A case report
- The JAK/STAT signaling pathway: from bench to clinic
- Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases
- The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
- A Subset of TREM2+ Dermal Macrophages Secretes Oncostatin M to Maintain Hair Follicle Stem Cell Quiescence and Inhibit Hair Growth
- Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib
- Alopecia Areata: An Updated Review for 2023
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- JAK Inhibitors for Treatment of Alopecia Areata
- Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention
- Integrated analysis of long non-coding RNA and mRNA expression in different colored skin of koi carp
- The Skin and Inflamm-Aging
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- Alopecia Areata: Current Treatments and New Directions
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- Role of janus kinase inhibitors in the treatment of alopecia areata
- SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion
- Inhibition of JAK-STAT Signaling with Baricitinib Reduces Inflammation and Improves Cellular Homeostasis in Progeria Cells
- Gene variants associated with acne vulgaris presentation and severity: a systematic review and meta-analysis
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Poster Presentations
- Alopecia Areata: Pathogenesis, Diagnosis, and Therapies
- British Association of Dermatologists guidelines for the management of people with cutaneous lupus erythematosus 2021
- Palmoplantar pustulosis–like eruption following tofacitinib therapy for juvenile idiopathic arthritis